uBiome is completely committed to meeting the most exacting standards. We were determined to put ourselves through the tough requirements for accreditation by the CAP, and the whole team is very gratified that our hard work has paid off.
San Francisco, CA (PRWEB) October 04, 2016
Following a rigorous on-site inspection, the leading microbial genomics testing company, uBiome, has been awarded accreditation to its San Francisco clinical laboratory by the highly respected College of American Pathologists (CAP).
Accreditation is only awarded to facilities meeting the highest standards of quality in laboratory services. With this recognition, the uBiome laboratory joins the prestigious ranks of some of the most prominent clinical laboratories in the world.
Although seeking accreditation from the CAP is voluntary, the U.S. federal government recognizes the CAP Laboratory Accreditation Program, which began in the early 1960s, as being equal to or more stringent than the government’s own inspection program, which is known as CLIA (Clinical Laboratory Improvements Amendments). uBiome’s laboratory became CLIA-certified in 2014. CAP accreditation is internationally recognized and seen as the “gold standard” for laboratories, above and beyond CLIA certification. Since so few CLIA-certified labs are also CAP-accredited, it now places uBiome’s laboratory among the top 2.75% facilities in the USA.
During the CAP accreditation process, inspectors examine the laboratory’s quality records, laboratory staff qualifications, validation of tests and systems, equipment, facilities, the safety program and overall management.
Dr. Jessica Richman, co-founder and CEO of uBiome, says: “uBiome is completely committed to meeting the most exacting standards. We were determined to put ourselves through the tough requirements for accreditation by the CAP, and the whole team is very gratified that our hard work has paid off.”
Dr. Zachary Apte, co-founder and CTO of uBiome adds: “The microbiome is an emerging field and we are one of the first clinical labs to explore its possibilities for human health. CAP accreditation is extremely well-respected, and we are pleased that we were able to meet their standards.”
The College of American Pathologists, with more than 18,000 members, is the world’s leading organization of board-certified pathologists. Its goal is to serve patients, physicians, and the public by encouraging, promoting, and supporting excellence in pathology and laboratory medicine. Pathology involves the examination of specimens of all kinds, in order to study and diagnose disease.
uBiome is the leading microbial genomics company. Funded by Y Combinator, Andreessen Horowitz, and other leading investors, uBiome pioneered the field of microbial genomics starting in 2012. Their Scientific Advisory Board includes Dr. Joseph DeRisi, MacArthur Genius Award Recipient and UCSF Professor; Dr. Atul Butte, Director of the Institute for Computational Health Sciences; Dr. Pablo Valenzuela, Inventor of Hepatitis B Vaccine and Founder of Chiron; Dr. Alan Greene, Leading Physician and uBiome CMO; Dr. Jonathan Eisen, UC Davis Professor; Dr. David Agus, Professor of Medicine and Engineering at the University of Southern California and Best Selling Author; and other leading physicians and scientists.
Ph: +1 (415) 212-9214